Bicycle Therapeutics Ltd (BCYC) Insider Trading
- $32,029,068.72
- $15,640,290.35
- April 2, 2025
- Kevin Lee
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 11, 2021 | CEO | 5,000 | $53.88 | Sell | $269,400.00 | |
Aug. 31, 2021 | CEO | 11,225 | $36.33 | Sell | $407,804.25 | |
Aug. 27, 2021 | CFO | 7,950 | $35.15 | Sell | $279,442.50 | |
Aug. 27, 2021 | CEO | 1,808 | $36.02 | Sell | $65,124.16 | |
Aug. 23, 2021 | CFO | 7,500 | $33.02 | Sell | $247,650.00 | |
July 29, 2021 | CFO | 12,500 | $31.51 | Sell | $393,875.00 | |
July 26, 2021 | CEO | 100 | $36.00 | Sell | $3,600.00 | |
July 23, 2021 | CEO | 4,782 | $36.02 | Sell | $172,247.64 | |
July 16, 2021 | CEO | 609 | $34.00 | Sell | $20,706.00 | |
July 14, 2021 | CEO | 14,465 | $34.34 | Sell | $496,728.10 | |
July 13, 2021 | Insider | 72,701 | $32.44 | Sell | $2,358,420.44 | |
July 13, 2021 | Director | 600 | $33.50 | Sell | $20,100.00 | |
July 12, 2021 | CEO | 1,936 | $32.04 | Sell | $62,029.44 | |
July 6, 2021 | Insider | 271 | $32.00 | Sell | $8,672.00 | |
May 6, 2021 | CEO | 1,716 | $32.14 | Sell | $55,152.24 | |
May 4, 2021 | CEO | 897 | $32.03 | Sell | $28,730.91 | |
April 30, 2021 | CEO | 58,919 | $30.86 | Sell | $1,818,240.34 | |
April 28, 2021 | CEO | 22,495 | $31.08 | Sell | $699,144.60 | |
April 26, 2021 | CEO | 18,611 | $31.28 | Sell | $582,152.08 | |
April 8, 2021 | Director | 24,838 | $31.71 | Sell | $787,612.98 | |
April 5, 2021 | Director | 162 | $31.07 | Sell | $5,033.34 | |
March 31, 2021 | Insider | 10,000 | $30.00 | Sell | $300,000.00 | |
March 17, 2021 | Director | 7,784 | $29.00 | Sell | $225,736.00 | |
March 15, 2021 | Insider | 217 | $28.00 | Sell | $6,076.00 | |
March 12, 2021 | Director | 2,216 | $29.00 | Sell | $64,264.00 | |
March 12, 2021 | Insider | 9,783 | $28.50 | Sell | $278,815.50 | |
Jan. 19, 2021 | CEO | 5,000 | $29.26 | Sell | $146,300.00 | |
Jan. 19, 2021 | CFO | 15,000 | $30.00 | Sell | $450,000.00 | |
Jan. 15, 2021 | CEO | 10,000 | $26.01 | Sell | $260,100.00 | |
Dec. 1, 2020 | CFO | 7,500 | $22.50 | Sell | $168,750.00 | |
Nov. 27, 2020 | CFO | 530 | $20.00 | Sell | $10,600.00 | |
Nov. 25, 2020 | CFO | 9,781 | $20.07 | Sell | $196,304.67 | |
Nov. 23, 2020 | CFO | 17,189 | $19.83 | Sell | $340,857.87 | |
July 14, 2020 | Major Shareholder | 1,597 | $19.27 | Sell | $30,774.19 | |
May 28, 2019 | Director | 385,714 | $14.00 | Buy | $5,399,996.00 | |
May 28, 2019 | Major Shareholder | 385,715 | $14.00 | Buy | $5,400,010.00 |
Insiders are both buying and selling Bicycle Therapeutics Ltd stock.
The insider traders at Bicycle Therapeutics Ltd are: Kevin Lee, Lee Kalowski, Travis Alvin Thompson, Nicholas Keen, Michael Skynner, Pierre Legault, Michael Charles Ferguso Hannay, Nigel Crockett, Alistair Milnes, Alethia Young, Bros. Advisors Lp Baker, Kate Bingham, Life Sciences Fund V Lp Sv, Plc Glaxosmithkline, Santiago Arroyo, and Deborah Harland
The most active insider trader at Bicycle Therapeutics Ltd is Kevin Lee with 27 trades.
Pierre Legault has sold the most Bicycle Therapeutics Ltd stock with a total value of $6,169,662.46.
Bros. Advisors Lp Baker has bought the most Bicycle Therapeutics Ltd stock with a total value of $28,899,062.72.
The most recent insider trade for Bicycle Therapeutics Ltd was on April 2, 2025.
The single biggest insider buy for Bicycle Therapeutics Ltd was from Bros. Advisors Lp Baker with a total value of $13,559,062.72 on Dec. 13, 2024.
The single biggest insider sell for Bicycle Therapeutics Ltd was from Pierre Legault with a total value of $2,543,508.07 on Dec. 21, 2021.